Nuvectis Pharma, Inc. (NVCT) Tops Q3 EPS by 1c

Nuvectis Pharma, Inc. (NASDAQ: NVCT) reported Q3 EPS of ($0.24), $0.01 better than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Nuvectis Pharma, Inc. (NVCT) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Invesco Mortgage Capital declares $0.12 monthly dividend for June 2026
• Ticketplus files for IPO with shares priced between $13-$15